Skip to main content
. 2018 Feb 9;10(4):317–339. doi: 10.2217/imt-2017-0122

Figure 2. . Immunotherapy strategies in clinical trials.

Figure 2. 

Glioma evades the immune system through a variety of ways. Antiglioma immunotherapeutic strategies are targeting T-cell exhaustion, immunosuppressive cells and angiogenesis and testing peptide or dendritic cell vaccines-based approaches to enhance the antitumor adaptive immune response or the activity of effector cells using chimeric antigen receptor T cells.